Keyphrases
National Cancer Institute
100%
Therapeutic Development
100%
Biologic Effect
60%
Antitumor Activity
40%
Pharmacology
20%
Drug Development
20%
Combination Therapy
20%
Blood Tissue
20%
Clinical Trials
20%
Radiotherapy
20%
Cancer Treatment
20%
Pharmacokinetic Drug Interactions
20%
Antitumor Agents
20%
New Agents
20%
Image Evaluation
20%
Phase II Study
20%
Dosing Schedule
20%
Cancer Therapy
20%
Therapy Evaluation
20%
Pharmacodynamics
20%
Geriatric Population
20%
Rapid Initiation
20%
Early Phase Clinical Trials
20%
Tumor Tissue
20%
Phase II Clinical Trial
20%
Special Patient Population
20%
Molecular Targets
20%
Cancer Targeting
20%
Data Reporting
20%
End-organ Function
20%
Cancer Diagnosis
20%
Evaluation Program
20%
Clinically Meaningful Outcomes
20%
Investigator-initiated Trials
20%
Contract-based
20%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Neoplasm
25%
Clinical Trial
25%
Pharmacodynamics
25%
Combination Therapy
12%
Molecular Target
12%
Drug Development
12%
Antitumor Activity
12%
Pharmacokinetics
12%